china digital currency crypto- Top searches

Yushi Technology: There is no factual basis for the company to be included in the "entity list". At present, the production and operation are normal. Yushi Technology issued a statement today: On December 10, 2024 (Beijing time), the Bureau of Industry and Security of the US Department of Commerce issued relevant announcements to include companies such as Yushi Technology in the entity list. There is no factual basis for this decision, and the company has never received any investigation and evidence collection work from any official US agency. We call on the US government to re-examine. Yushi Technology is an independent private enterprise. As a global provider of AloT products, solutions and full-stack capabilities, Yushi Technology has always adhered to the internationally accepted business ethics and compliance management concept since its establishment 13 years ago, abided by the duties of commercial companies and strictly abided by the laws and regulations of the countries where it operates. At present, the company's production and operation are normal, and this incident has no significant adverse impact on the company's operation. We have the ability to ensure continuous and stable product supply and high-quality technical support for global customers.Xinshida Inverter has successfully obtained the type approval certificate of China Classification Society. Recently, Xinshida Inverter AS710M has successfully obtained the type approval certificate issued by China Classification Society (CCS), which indicates that Xinshida Electric's products meet the strict standards of the international shipping industry, and also indicates that the company will further expand its market share in the field of ship and ocean engineering.Tang Daizhi, the former deputy chief economist of China Offshore Oil Group Co., Ltd., was investigated. According to the news from the Discipline Inspection and Supervision Team of China Offshore Oil Group Co., Ltd. and the Supervision Committee of Jiangsu Provincial Commission for Discipline Inspection, Tang Daizhi, the former deputy chief economist of China Offshore Oil Group Co., Ltd., the general manager of human resources department and the head of party organization department, is suspected of serious violation of discipline and law, and is currently under disciplinary review and supervision investigation by the Discipline Inspection and Supervision Team of China Offshore Oil Group Co., Ltd. and the Jiangsu Provincial Supervision Committee.

Trader: The Indian central bank is suspected of selling dollars to limit the depreciation of Indian Rupee.The semiconductor concept oscillated higher and Broadcom integrated daily limit, and the semiconductor concept oscillated higher and Broadcom integrated daily limit. Hengxuan Technology, Purran, Shanghai Beiling, Tailingwei and Dongxin shares rose more than 5%.JPMorgan Chase: The momentum of Xiaomi's electric vehicle will continue to be rated as "overweight". According to a research report published by JPMorgan Chase, Xiaomi Group announced that it will launch the second electric vehicle named Xiaomi Yuqi in the middle of next year, which is an SUV model. The product portfolio of electric vehicle business continues to expand, reflecting that the Group's ability to enter the electric vehicle market is better than market expectations. The delivery target of Xiaomi SU7, the first electric vehicle, has also been raised twice, and the gross profit margin of electric vehicle business has reached a medium-high level in the first two quarters, far exceeding the initial market expectation and only recorded a slight gross profit margin. Motong said that at present, we are waiting for the Group to announce more details about the new car's life, pricing and battery. We believe that the strong sales momentum of SU7, the profitability of the Group's core business and electric vehicle business, and the expectation that new models will be launched in the second half of next year will continue to promote the stock price in the next 6 to 12 months. The positive catalysts in the future include more details or pricing of YU7, further expansion of electric vehicle production capacity, exceeding expectations in core business performance, and large-scale and national consumption stimulus measures introduced by the country in the future.

Afternoon comment: the three major indexes rose slightly in half a day, and the concept of Shanghai's state-owned enterprise reform lifted the tide of daily limit. The three major indexes opened lower and went higher in early trading and rose slightly in half a day. In terms of sectors, the concept of Shanghai's state-owned enterprise reform is on the rise, and Shanghai Material Trade, First Medicine and Shibei High-tech are collectively on the rise. The retail sector continued to be strong, with the daily limit of Youa, Zhongbai Group and Maoye Commercial. The concept of AI glasses is higher, and Tianjian shares and Star Technology both have a daily limit of 20cm; Insurance stocks continued to adjust, and Tianmao Group fell to an intraday limit; Sora concept stocks collectively adjusted back, and the word Huayang Lianzhong fell; Bank shares fluctuated lower, with Bank of Ningbo leading the decline. Overall, stocks rose more and fell less, with more than 3,500 stocks rising. On the disk, Shanghai's state-owned enterprise reform, AI glasses and retail sectors were among the top gainers, while insurance, Sora concept and banking sectors were among the top losers.AI glasses concept stocks continued to rise, with Zhongke Lanxun, Hengxuan Technology and Mingyue Lens rising more than 12%, while Tianjian, Xingxing Technology, Yiyuan Communication, Yitong Communication and Zhuoyi Technology had previous daily limit.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.